Webinar :Register now for webinar on 'Trade BankNifty in just 15 minutes a day' - By Asmita Patel
you are here: HomeNewsBusiness
Last Updated : Oct 20, 2020 11:40 AM IST | Source: PTI

Strides receives USFDA approval for Ethacrynic Acid Tablets

The product is a generic version of Edecrin Tablets, 25 mg, of Bausch Health Americas, Inc., the company said in a statement.

PTI
Representative image
Representative image
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Strides Pharma Science Limited on Tuesday announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Ltd, Singapore, has received approval forEthacrynic Acid Tablets USP, 25 mgfrom the United States Food & Drug Administration (USFDA).

The product is a generic version of Edecrin Tablets, 25 mg, of Bausch Health Americas, Inc., the company said in a statement.

The product would be manufactured at the companys flagship facility here and marketed by Strides Pharma Inc. in the US market, it said.
First Published on Oct 20, 2020 11:40 am
Sections